Clinical trials have not shown the superiority of one Wegovy injection location over the other
While Wegovy is a well-studied medication, those studies were done in people with obesity or overweight
doi.org/10.1016/j.obpill.2024.100143 Author: Molly Pelletier, MS, RD , is a Registered Dietitian specializing in Gastroesophageal Reflux Disease (GERD), Laryngopharyngeal Reflux (LPR), and integrative gut health nutrition
Many prefer taking it first thing in the morning to provide antioxidant support for the day ahead
To be eligible, participants had to be between 25 and 40 years of age, to be healthy as per site physician medical assessment, to be working for 812 h per day, and to have a body mass index (BMI) between 18.5 and 27.5 kg/m 2